ArticleCancer medicine2026

Use of Metronomic Chemotherapy in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: A Retrospective Multicenter Study.

Lara Laini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.